• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌骨转移:癌细胞的迁徙之旅

Switching Homes: How Cancer Moves to Bone.

机构信息

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

出版信息

Int J Mol Sci. 2020 Jun 9;21(11):4124. doi: 10.3390/ijms21114124.

DOI:10.3390/ijms21114124
PMID:32527062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7313057/
Abstract

Bone metastases (BM) are a very common complication of the most prevalent human cancers. BM are extremely painful and may be life-threatening when associated with hypercalcaemia. BM can lead to kidney failure and cardiac arrhythmias and arrest, but why and how do cancer cells decide to "switch homes" and move to bone? In this review, we will present what answers science has provided so far, with focus on the molecular mechanisms and cellular aspects of well-established findings, such as the concept of "vicious cycle" and "osteolytic" vs. "osteosclerotic" bone metastases; as well as on novel concepts, such as cellular dormancy and extracellular vesicles. At the molecular level, we will focus on hypoxia-associated factors and angiogenesis, the Wnt pathway, parathyroid hormone-related peptide (PTHrP) and chemokines. At the supramolecular/cellular level, we will discuss tumour dormancy, id est the mechanisms through which a small contingent of tumour cells coming from the primary site may be kept dormant in the endosteal niche for many years. Finally, we will present a potential role for the multimolecular mediators known as extracellular vesicles in determining bone-tropism and establishing a premetastatic niche by influencing the bone microenvironment.

摘要

骨转移(BM)是最常见人类癌症的一种非常常见的并发症。BM 非常疼痛,当伴有高钙血症时可能危及生命。BM 可导致肾衰竭和心律失常和骤停,但癌细胞为什么以及如何决定“换家”并转移到骨骼?在这篇综述中,我们将介绍科学迄今为止提供的答案,重点介绍已确立发现的分子机制和细胞方面,例如“恶性循环”和“溶骨性”与“成骨性”骨转移的概念;以及新的概念,如细胞休眠和细胞外囊泡。在分子水平上,我们将重点关注缺氧相关因子和血管生成、Wnt 通路、甲状旁腺激素相关肽(PTHrP)和趋化因子。在超分子/细胞水平上,我们将讨论肿瘤休眠,即从原发性部位而来的一小部分肿瘤细胞通过何种机制在骨内膜龛中长期保持休眠状态。最后,我们将介绍称为细胞外囊泡的多分子介体在通过影响骨微环境来决定骨骼趋向性和建立前转移龛中可能发挥的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/799f/7313057/fc81b442bc36/ijms-21-04124-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/799f/7313057/fc81b442bc36/ijms-21-04124-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/799f/7313057/fc81b442bc36/ijms-21-04124-g001.jpg

相似文献

1
Switching Homes: How Cancer Moves to Bone.癌骨转移:癌细胞的迁徙之旅
Int J Mol Sci. 2020 Jun 9;21(11):4124. doi: 10.3390/ijms21114124.
2
The multifaceted actions of PTHrP in skeletal metastasis.甲状旁腺激素相关蛋白在骨骼转移中的多效作用。
Future Oncol. 2012 Jul;8(7):803-17. doi: 10.2217/fon.12.76.
3
Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.恶性肿瘤高钙血症及骨溶骨性和成骨性转移相关机制的基础研究
Endocr Relat Cancer. 2005 Sep;12(3):549-83. doi: 10.1677/erc.1.00543.
4
Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis.炎症微环境中的肿瘤休眠:一种有前途的癌症相关骨转移治疗策略。
Cell Mol Life Sci. 2020 Dec;77(24):5149-5169. doi: 10.1007/s00018-020-03572-1. Epub 2020 Jun 16.
5
Molecular mechanisms of tumor-bone interactions in osteolytic metastases.溶骨性转移中肿瘤与骨相互作用的分子机制
Crit Rev Eukaryot Gene Expr. 2000;10(2):159-78.
6
PTHrP regulates angiogenesis and bone resorption via VEGF expression.甲状旁腺激素相关蛋白通过血管内皮生长因子的表达来调节血管生成和骨吸收。
Anticancer Res. 2010 Jul;30(7):2755-67.
7
The Role of Extracellular Vesicles in Bone Metastasis.细胞外囊泡在骨转移中的作用。
Int J Mol Sci. 2018 Apr 10;19(4):1136. doi: 10.3390/ijms19041136.
8
Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis.成骨细胞和破骨细胞:肿瘤细胞骨转移休眠期的重要开关。
J Exp Clin Cancer Res. 2022 Oct 28;41(1):316. doi: 10.1186/s13046-022-02520-0.
9
Secreted microRNAs in bone metastasis.骨转移中的分泌型 microRNAs。
J Bone Miner Metab. 2023 May;41(3):358-364. doi: 10.1007/s00774-023-01424-z. Epub 2023 Apr 8.
10
Molecular mechanisms of breast cancer metastases to bone.乳腺癌转移至骨的分子机制。
Clin Breast Cancer. 2005 Feb;5 Suppl(2):S46-53. doi: 10.3816/cbc.2005.s.004.

引用本文的文献

1
Prediction of bone oligometastases in breast cancer using models based on deep learning radiomics of PET/CT imaging.使用基于PET/CT成像深度学习影像组学的模型预测乳腺癌骨寡转移。
Front Oncol. 2025 Aug 21;15:1621677. doi: 10.3389/fonc.2025.1621677. eCollection 2025.
2
ADAM19 cleaves the PTH receptor and associates with brachydactyly type E.ADAM19 酶切甲状旁腺激素受体,并与短指症 E 型相关。
Life Sci Alliance. 2024 Feb 8;7(4). doi: 10.26508/lsa.202302400. Print 2024 Apr.
3
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients.

本文引用的文献

1
The force awakens: metastatic dormant cancer cells.力觉醒:转移性休眠癌细胞。
Exp Mol Med. 2020 Apr;52(4):569-581. doi: 10.1038/s12276-020-0423-z. Epub 2020 Apr 16.
2
The Endosteal Niche in Breast Cancer Bone Metastasis.乳腺癌骨转移中的骨内膜微环境。
Front Oncol. 2020 Mar 13;10:335. doi: 10.3389/fonc.2020.00335. eCollection 2020.
3
Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles.通过细胞外囊泡监测癌症的治疗效率。
自发性破骨细胞生成,晚期腔面A型乳腺癌患者发生骨转移的一个风险因素。
Front Oncol. 2023 Feb 20;13:1073793. doi: 10.3389/fonc.2023.1073793. eCollection 2023.
4
Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials.目前对地诺单抗(RANKL中和抗体)治疗恶性肿瘤骨转移的全面理解,包括药理机制和临床试验。
Front Oncol. 2023 Feb 13;13:1133828. doi: 10.3389/fonc.2023.1133828. eCollection 2023.
5
Newly Released Advances in the Molecular Mechanisms of Osseous Metastasis and Potential Therapeutic Strategies.骨转移分子机制的最新进展及潜在治疗策略
Arch Bone Jt Surg. 2022 Sep;10(9):741-755. doi: 10.22038/ABJS.2022.57856.2865.
6
Liquid biopsies in primary and secondary bone cancers.原发性和继发性骨癌中的液体活检
Cancer Drug Resist. 2022 Jun 21;5(3):541-559. doi: 10.20517/cdr.2022.17. eCollection 2022.
7
How to Target Spinal Metastasis in Experimental Research: An Overview of Currently Used Experimental Mouse Models and Future Prospects.如何在实验研究中靶向脊柱转移:目前使用的实验小鼠模型概述及未来展望。
Int J Mol Sci. 2021 May 21;22(11):5420. doi: 10.3390/ijms22115420.
8
Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment.载唑来膦酸的β-磷酸三钙抑制肿瘤增殖和破骨细胞活化:用于高效骨肉瘤治疗的功能性骨替代物的研发
Int J Mol Sci. 2021 Feb 14;22(4):1889. doi: 10.3390/ijms22041889.
9
Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases.个性化医疗与骨转移:生物标志物、微小RNA与骨转移
Cancers (Basel). 2020 Jul 29;12(8):2109. doi: 10.3390/cancers12082109.
Cells. 2020 Jan 6;9(1):130. doi: 10.3390/cells9010130.
4
A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis.晚期非小细胞肺癌中HIF-1α表达与骨转移之间的密切关系:一项回顾性分析
Oncotarget. 2019 Dec 17;10(66):7071-7079. doi: 10.18632/oncotarget.27378.
5
Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy.转移性肿瘤休眠的机制及其对癌症治疗的意义。
Int J Mol Sci. 2019 Dec 6;20(24):6158. doi: 10.3390/ijms20246158.
6
Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers.经典WNT/β-连环蛋白信号通路在癌症中的多个靶点
Front Oncol. 2019 Nov 18;9:1248. doi: 10.3389/fonc.2019.01248. eCollection 2019.
7
Assessment of methods for serum extracellular vesicle small RNA sequencing to support biomarker development.用于支持生物标志物开发的血清细胞外囊泡小RNA测序方法的评估
J Extracell Vesicles. 2019 Nov 5;8(1):1684425. doi: 10.1080/20013078.2019.1684425. eCollection 2019.
8
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy.MMP9 调节乳腺癌抗转移治疗的转移级联和免疫景观。
Life Sci Alliance. 2019 Nov 14;2(6). doi: 10.26508/lsa.201800226. Print 2019 Dec.
9
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.单核细胞趋化蛋白-1(MCP-1/CCL2)驱动骨重塑和骨骼转移的激活。
Curr Osteoporos Rep. 2019 Dec;17(6):538-547. doi: 10.1007/s11914-019-00545-7.
10
Determination of variability due to biological and technical variation in urinary extracellular vesicles as a crucial step in biomarker discovery studies.确定尿液细胞外囊泡中生物和技术变异所导致的变异性,作为生物标志物发现研究的关键步骤。
J Extracell Vesicles. 2019 Oct 13;8(1):1676035. doi: 10.1080/20013078.2019.1676035. eCollection 2019.